News

Chris Preti Joins Company as President

Press ReleaseApril 16, 2018

January 22, 2018 – Jubilant Pharma announces the appointment of Chris Preti to the position of President for its allergy company, HollisterStier Allergy. Mr. Preti has over 25 years of progressive pharmaceutical experience. He began his career at GlaxoSmithKline in research and development, developing products for regulatory submission across multiple therapeutic areas. He then joined…

Details

AAAAI | ACAAI Venom Extract Shortage Task Force Report

Industry News, Press ReleaseFebruary 23, 2017

Joint Message Announcing Venom Extract Shortage Task Force Report The AAAAI and ACAAI previously announced a venom extract shortage due to ALK – Abello A/S experiencing a manufacturing delay in regards to its venom products. In response, we formed a task force of experts to generate guidance outlining recommendations for our members which could lead…

Details

WARNING Important Safety Information

See full prescribing information for complete boxed warning.

Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions, including anaphylactic shock and in rare cases death, especially in patients who have severe or steroid-dependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. This product is intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

Adverse Reactions

Adverse reactions on our products can be reported by calling 800-495-7437, or by sending us an email. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 800-FDA-1088.

For full prescribing information see our package inserts here

Privacy Policy

Our Privacy Policy has been updated. To give you a better understanding of how we treat your data, please review this Privacy Policy

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Review our use of cookies for more details.

Compliance Program

View our statement of compliance here

Warning Message